Valérie Molinier‐Frenkel

Human IL4I1 is a secreted l-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation

Marie‐Laure Boulland, Jeanine Marquet, Valérie Molinier‐Frenkel et al. · Blood · 2007 · 194 citations · Full text

Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response

Valérie Molinier‐Frenkel, Renée Lengagne, Florence Gaden et al. · Journal of Virology · 2002 · 166 citations · Full text

Immunology, Viral Pathogenesis, Viral Structural Protein +16

Phase I Study of Dystrophin Plasmid-Based Gene Therapy in Duchenne/Becker Muscular Dystrophy

Norma B. Romero, Serge Braun, Olivier Benvéniste et al. · Human Gene Therapy · 2004 · 149 citations

Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products.

Hanne Gahéry‐Ségard, Valérie Molinier‐Frenkel, Christophe Le Boulaire et al. · Journal of Clinical Investigation · 1997 · 117 citations · Full text

Cancer Immunosurveillance, Cancer-associated Virus, Tumor Microenvironment +14

The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages

Amélie Carbonnelle-Puscian, Christiane Copie‐Bergman, Maryse Baia et al. · Leukemia · 2009 · 116 citations · Full text

Lymphoid Neoplasia, Tumor-associated Macrophages, Autoimmune Disease +11